End of the drill?
For many patients, dentistry’s core philosophy has remained surprisingly unchanged; search, drill, fill or replace.
When teeth erode, they are patched with synthetic resins. When they die, they are drilled out and crowned. When they are lost entirely, titanium posts are screwed into the jawbone. The profession has become masters of dental ‘carpentry’, according to those same patients. Ok, the reality is more sophisticated and nuanced. But an implant or fill is still an inanimate proxy; an inorganic patch in a dynamic, living ecosystem.
That long-standing paradigm is potentially going to change. Over the past three months, a wave of breakthroughs in biological tissue engineering and monoclonal antibody therapies has shifted dental medicine from passive repair to active biological regeneration. We are, perhaps, witnessing the dawn of a new era where lost enamel, damaged dentin and even entire missing teeth can potentially be regrown on demand.
The most profound shift lies in the mechanics of tissue scaffolding. In September, researchers at King’s College London and Imperial College London solved one of regenerative medicine’s trickiest puzzles; how to reliably grow complex human tooth organoids without relying on unpredictable, animal-derived matrices.
By developing synthetic, bio-orthogonally cross-linked hydrogels, the team created a pristine environment that precisely mimics the chemical signals of the embryonic human jaw. Because these synthetic gels produce zero toxic cellular by-products and can be manufactured with mathematical precision, they provide the canvas necessary to grow viable tooth buds; complete with enamel, dentin and vascular pulp.
Simultaneously, material scientists at the University of Nottingham introduced a complementary breakthrough aimed at immediate, micro-scale restoration; a protein-based smart gel applied directly to eroded enamel. Instead of requiring a dentist to drill away sound structure to hold a filling, the gel binds with minerals already floating in the patient’s saliva to mineralise new, enamel-like layers over exposed dentin. It is restorative dentistry operating at the molecular level, potentially rendering the terrifying whine of the high-speed drill obsolete for early-stage decay.
Perhaps the most radical frontier is happening not in the petri dish, but in clinical trials. Japanese biotech Toregem BioPharma advanced its flagship monoclonal antibody drug, TRG035, into Phase IIa human trials following regulatory clearance from Japan’s Pharmaceuticals and Medical Devices Agency. The drug targets USAG-1, a specific protein that naturally acts as a molecular brake on tooth development. By temporarily inhibiting USAG-1, the therapy instructs dormant tooth buds sleeping beneath the gumline to effectively wake up and begin forming a brand-new, permanent adult tooth. Originally targeted at children with hypodontia, the ongoing success of this molecular switch opens the door for adults who have lost teeth to decay, trauma or gum disease to simply grow a new set.
The implications of this shift extend far beyond aesthetics or convenience; they fundamentally redefine public health economics. Traditional dental care is famously reactive and structurally expensive; a cycle of repeated fillings, crowns, root canals and eventual extractions over a lifetime. Biological solutions, though initially in their early stages, hold the potential to break this restorative cycle entirely. A single targeted course of regenerative therapy could solve a missing-tooth problem permanently with self-repairing, vascularised biological tissue, rather than requiring decades of hardware maintenance and implant replacements.
Naturally, major clinical hurdles remain before these treatments become mainstream. Scaling laboratory-grown organoids into predictable, standardised clinical protocols takes time. It is, obviously, essential to ensure that molecular therapies targeting growth proteins operate with absolute precision, confining their biological effects strictly to the maxilla and mandible. But the trajectory is unmistakable. For decades, dentistry has asked: How do we manufacture a better artificial replacement? Today, the field asks: How do we prompt the body to rebuild itself? The era of dental carpentry is giving way to the era of dental biology. Soon, visiting the dentist may not mean bracing for a needle and a drill; it will mean handing your body the biological instructions to grow a better smile.
Will Peakin editor@sdmag.co.uk. Follow Scottish Dental on Instagram, Facebook and LinkedIn.